Abstract: A flexible stretchable sensor, methods of use, and methods of forming the same are disclosed herein. In one implementation, the flexible stretchable sensor comprises a plurality of flexible and stretchable fibers in close proximity to one another, wherein each of the flexible fibers comprises a hollow electrically insulating elastomeric fiber at least partially filled with a flexible and stretchable conductive material and an electrical connector in electrical communication with the flexible and stretchable conductive material, wherein a change in an electrical parameter of at least one of the plurality of flexible and stretchable fibers is used to sense an event associated with the at least one of the plurality of flexible and stretchable fibers.

Abstract: Voltage controlled reconfiguration of liquid metal structures by providing an electrolyte in the container. A liquid metal structure is provided in the container and at least partially in contact with the electrolyte. A voltage is applied between the liquid metal structure and the electrolyte to change the shape of the liquid metal structure such that the structure achieves a desired shape for an electrical, optical, mechanical, or thermal application.

Abstract: There is provided a film coated pharmaceutical composition comprising 5?-deoxy-5-fluoro-N-[(pentyloxy)-carbonyl]-cytidine (capecitabine) and at least one disintegrant selected from the group comprising of crospovidone (particle size <15-400?), croscarmellose sodium, sodium starch glycolate, low-substituted hydroxypropylcellulose, Pharmaburst C or any combination of these, together with other pharmaceutically acceptable excipients to form a rapidly disintegrating tablet. This tablet disintegrates in water at 37° C. in a USP Disintegration Apparatus in less than 2 minutes, preferably 1 minute and have a hardness of 8-13 strong Cobb-Units.

Abstract: There is provided a film coated pharmaceutical composition comprising 5?-deoxy-5-fluoro-N-[(pentyloxy)-carbonyl]-cytidine (capecitabine) and at least one disintegrant selected from the group comprising of crospovidone (particle size <15-400?), croscarmellose sodium, sodium starch glycolate, low-substituted hydroxypropylcellulose, Ludiflash® or any combination of these, together with other pharmaceutically acceptable excipients to form a rapidly disintegrating tablet.

Abstract: There is provided a film coated pharmaceutical composition comprising 5?-deoxy-5-fluoro-N-[(pentyloxy)-carbonyl]-cytidine (capecitabine) and at least one disintegrant selected from the group comprising of crospovidone (particle size <15-400?), croscarmellose sodium, sodium starch glycolate, low-substituted hydroxypropylcellulose, Pharmaburst C or any combination of these, together with other pharmaceutically acceptable excipients to form a rapidly disintegrating tablet. This tablet disintegrates in water at 37° C. in a USP Disintegration Apparatus in less than 2 minutes, preferably 1 minute and have a hardness of 8-13 strong Cobb-Units.